source
- World's first personalized gene-editing therapy costs $1.65 million per patient, project director saysAt a rare disease conference in Oxford, Fyodor Urnov disclosed that the world's first therapy designed to correct an individual’s unique genetic mutation cost $1.65 million to produce. The treatme…
- Boston biotech seed funding drops 40% as investors favor later-stage firmsBoston remains the world’s largest biotech hub, but early‑stage startups are feeling a sharp squeeze in capital. The average seed round for a pre‑clinical company in Massachusetts fell to $4.65 mi…